Summary
The development of vaccines, conventional protein based as well as nucleic acid based vaccines, and their delivery systems has been largely empirical and ineffective. This is partly due to a lack of methodology, since traditionally only a few markers are studied. By introducing gene expression analysis and bioinformatics into the design of vaccines and their delivery systems, vaccine development can be improved and accelerated considerably. Each vaccine antigen and delivery system combination is characterized by a unique genomic profile, a “fingerprint” that will give information of not only immunological and toxicological responses but also other related cellular responses e.g. cell cycle, apoptosis and carcinogenic effects. The resulting unique genomic fingerprint facilitates the establishment of molecular structure – pharmacological activity relationships and therefore leads to optimization of vaccine development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S., and Gupta, C.K. (1993) Adjuvants–a balance between toxicity and adjuvanticity. Vaccine. 11, 293–306.
Food and Drug Administration (FDA) Washington D.C. (1996) Preliminary guidelines for the manufacture and evaluation of DNA vaccines. Rockville, MD: Food and Drug Administration, Center for Biologics Evaluation and Research. Docket 96N-0400.
Bussiere, J.L., Mc Cormick, G.C., and Green, J.D. (1995) In Vaccine design: the subunit and adjuvant approach (M.F. Powell and M.J. Newman, eds.), Plenum Press, New York, pp. 61–79.
Regnström, K., Ragnarsson, E.G.E., Rydell, N., Sjöholm, I., and Artursson, P. (2002) Tetanus antigen modulates the gene expression profile of aluminum phosphate adjuvant in spleen lymphocytes in vivo. Pharmacogenomics J. 2, 57–64.
Regnström, K., Ragnarsson, E.G.E., and Artursson, P. (2003) Gene expression after vaccination of mice with formulations of diphtheria- or tetanus toxoid and different adjuvants: arrays identify shared immune response genes and vaccine-specific genes in spleen lymphocytes. Vaccine. 21, 2307–2317.
Regnström, K., Ragnarsson, E.G.E., Köping-Höggård, M., Torstensson, L., Nyblom, N., and Artursson, P. (2003) PEI–a potent, but not harmless, mucosal immunostimulator of mixed T-helper cell response and FasL mediated cell death in mice. Gene Ther. 10,1575–1583.
Regnström, K., Ragnarsson, E.G.E., Fryknäs, M., Köping-Höggård, M., and Artursson, P. (2006) Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for non-viral gene delivery. Pharm. Res. 23, 475–482.
Bucy, R.P., Panoskaltsis-Mortari, A., Huang, G., et al. (1994) Heterogenicity of single cell cytokine gene expression in clonal T cell populations. J. Exp. Med. 180, 1251–1262.
Lazaridis, M. (2001) Course in statistical analysis of micro array studies. Presented at: Ninth International Conference on Intelligent Systems for Molecular Biology; Copenhagen; July.
Gieser, P., Bloom, G.C., and Lazaridis, E.N. (2002) Introduction to microarray experimentation and analysis, in Biostatistical methods (S. W. Looney, ed.), Methods in Molecular Biology, Humana Press, Totowa, NJ, 184:29–49.
Teague, T.K., Hildeman, D., Kedl, R.M., et al. (1999) Activation changes the spectrum but not the diversity of genes expressed in T cells. Proc. Natl. Acad. Sci. U. S. A. 98, 12691–12696.
Tamayo, P., Slonim, D., Mesirov, J., et al. (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. U. S. A. 96, 2907–2912.
Eisen, M.B., Spellman, P.T., Brown, P.O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95, 14863–14868.
Bachmair, F., Huber, C.G., and Daxenbichler, G. (2002) Quantitation of gene expression by RT-PCR and HPLC analysis of PCR products, in Quantitative RT-PCR in RT-PCR protocols (J. O'Connell, ed.) Humana, Totowa, NJ, pp. 103–116.
Jensen, T.K., Laegreid, A., Komorowski, J., and Hovig, E. (2001) A literature network of human genes for high-throughput analysis of gene expression. Nat. Genet. 28, 21–28.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Regnström, K.J. (2008). Pharmacogenomics in the Preclinical Development of Vaccines. In: Yan, Q. (eds) Pharmacogenomics in Drug Discovery and Development. Methods in Molecular Biology™, vol 448. Humana Press. https://doi.org/10.1007/978-1-59745-205-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-59745-205-2_16
Publisher Name: Humana Press
Print ISBN: 978-1-58829-887-4
Online ISBN: 978-1-59745-205-2
eBook Packages: Springer Protocols